Works matching IS 13479032 AND DT 2021 AND VI 112 AND IP 4
Results: 34
In this Issue: Volume 112, Issue 4, April 2020.
- Published in:
- Cancer Science, 2021, v. 112, n. 4, p. 1337, doi. 10.1111/cas.14880
- Publication type:
- Article
The novel driver gene ASAP2 is a potential druggable target in pancreatic cancer.
- Published in:
- Cancer Science, 2021, v. 112, n. 4, p. 1655, doi. 10.1111/cas.14858
- By:
- Publication type:
- Article
Correction.
- Published in:
- Cancer Science, 2021, v. 112, n. 4, p. 1670, doi. 10.1111/cas.14856
- Publication type:
- Article
Vascular reconstitution in the tumor for more effective tumor immunotherapy.
- Published in:
- Cancer Science, 2021, v. 112, n. 4, p. 1348, doi. 10.1111/cas.14854
- By:
- Publication type:
- Article
Revertant somatic mosaicism as a cause of cancer.
- Published in:
- Cancer Science, 2021, v. 112, n. 4, p. 1383, doi. 10.1111/cas.14852
- By:
- Publication type:
- Article
Prospective study to validate the clinical utility of DNA diagnosis of peritoneal fluid cytology test in gastric cancer.
- Published in:
- Cancer Science, 2021, v. 112, n. 4, p. 1644, doi. 10.1111/cas.14850
- By:
- Publication type:
- Article
Comprehensive genomic analysis identifying heterogeneity in peripheral T‐cell lymphoma.
- Published in:
- Cancer Science, 2021, v. 112, n. 4, p. 1339, doi. 10.1111/cas.14849
- By:
- Publication type:
- Article
Anti‐tumor efficacy of human anti‐c‐met CAR‐T cells against papillary renal cell carcinoma in an orthotopic model.
- Published in:
- Cancer Science, 2021, v. 112, n. 4, p. 1417, doi. 10.1111/cas.14835
- By:
- Publication type:
- Article
Advanced colorectal cancer subtypes (aCRCS) help select oxaliplatin‐based or irinotecan‐based therapy for colorectal cancer.
- Published in:
- Cancer Science, 2021, v. 112, n. 4, p. 1567, doi. 10.1111/cas.14841
- By:
- Publication type:
- Article
The noncanonical role of EZH2 in cancer.
- Published in:
- Cancer Science, 2021, v. 112, n. 4, p. 1376, doi. 10.1111/cas.14840
- By:
- Publication type:
- Article
HIF‐1α downregulation of miR‐433‐3p in adipocyte‐derived exosomes contributes to NPC progression via targeting SCD1.
- Published in:
- Cancer Science, 2021, v. 112, n. 4, p. 1457, doi. 10.1111/cas.14829
- By:
- Publication type:
- Article
The multigene classifiers 95GC/42GC/155GC for precision medicine in ER‐positive HER2‐negative early breast cancer.
- Published in:
- Cancer Science, 2021, v. 112, n. 4, p. 1369, doi. 10.1111/cas.14838
- By:
- Publication type:
- Article
ASK1 suppresses NK cell‐mediated intravascular tumor cell clearance in lung metastasis.
- Published in:
- Cancer Science, 2021, v. 112, n. 4, p. 1633, doi. 10.1111/cas.14842
- By:
- Publication type:
- Article
Characteristics of B lymphocyte infiltration in HPV<sup>+</sup> head and neck squamous cell carcinoma.
- Published in:
- Cancer Science, 2021, v. 112, n. 4, p. 1402, doi. 10.1111/cas.14834
- By:
- Publication type:
- Article
Epstein‐Barr virus latent membrane protein‐1 upregulates autophagy and promotes viability in Hodgkin lymphoma: Implications for targeted therapy.
- Published in:
- Cancer Science, 2021, v. 112, n. 4, p. 1589, doi. 10.1111/cas.14833
- By:
- Publication type:
- Article
Forecasting sensitive targets of the kynurenine pathway in pancreatic adenocarcinoma using mathematical modeling.
- Published in:
- Cancer Science, 2021, v. 112, n. 4, p. 1481, doi. 10.1111/cas.14832
- By:
- Publication type:
- Article
LPAR5 promotes thyroid carcinoma cell proliferation and migration by activating class IA PI3K catalytic subunit p110β.
- Published in:
- Cancer Science, 2021, v. 112, n. 4, p. 1624, doi. 10.1111/cas.14837
- By:
- Publication type:
- Article
NAFLD exacerbates cholangitis and promotes cholangiocellular carcinoma in mice.
- Published in:
- Cancer Science, 2021, v. 112, n. 4, p. 1471, doi. 10.1111/cas.14828
- By:
- Publication type:
- Article
Capmatinib in Japanese patients with MET exon 14 skipping–mutated or MET‐amplified advanced NSCLC: GEOMETRY mono‐1 study.
- Published in:
- Cancer Science, 2021, v. 112, n. 4, p. 1556, doi. 10.1111/cas.14826
- By:
- Publication type:
- Article
Conditional Ror1 knockout reveals crucial involvement in lung adenocarcinoma development and identifies novel HIF‐1α regulator.
- Published in:
- Cancer Science, 2021, v. 112, n. 4, p. 1614, doi. 10.1111/cas.14825
- By:
- Publication type:
- Article
Body mass index and colorectal cancer risk: A Mendelian randomization study.
- Published in:
- Cancer Science, 2021, v. 112, n. 4, p. 1579, doi. 10.1111/cas.14824
- By:
- Publication type:
- Article
The impact of molecular profile on the lymphatic spread pattern in stage III colon cancer.
- Published in:
- Cancer Science, 2021, v. 112, n. 4, p. 1545, doi. 10.1111/cas.14819
- By:
- Publication type:
- Article
Correction.
- Published in:
- Cancer Science, 2021, v. 112, n. 4, p. 1669, doi. 10.1111/cas.14818
- Publication type:
- Article
IMpower132: Atezolizumab plus platinum‐based chemotherapy vs chemotherapy for advanced NSCLC in Japanese patients.
- Published in:
- Cancer Science, 2021, v. 112, n. 4, p. 1534, doi. 10.1111/cas.14817
- By:
- Publication type:
- Article
CircPVT1 promotes progression in clear cell renal cell carcinoma by sponging miR‐145‐5p and regulating TBX15 expression.
- Published in:
- Cancer Science, 2021, v. 112, n. 4, p. 1443, doi. 10.1111/cas.14814
- By:
- Publication type:
- Article
HMGB1 is a key factor for tamoxifen resistance and has the potential to predict the efficacy of CDK4/6 inhibitors in breast cancer.
- Published in:
- Cancer Science, 2021, v. 112, n. 4, p. 1603, doi. 10.1111/cas.14813
- By:
- Publication type:
- Article
Inhibition of vascular adhesion protein‐1 enhances the anti‐tumor effects of immune checkpoint inhibitors.
- Published in:
- Cancer Science, 2021, v. 112, n. 4, p. 1390, doi. 10.1111/cas.14812
- By:
- Publication type:
- Article
Preclinical and clinical advances in dual‐target chimeric antigen receptor therapy for hematological malignancies.
- Published in:
- Cancer Science, 2021, v. 112, n. 4, p. 1357, doi. 10.1111/cas.14799
- By:
- Publication type:
- Article
circ_100984‐miR‐432‐3p axis regulated c‐Jun/YBX‐1/β‐catenin feedback loop promotes bladder cancer progression.
- Published in:
- Cancer Science, 2021, v. 112, n. 4, p. 1429, doi. 10.1111/cas.14774
- By:
- Publication type:
- Article
Treatment and relapse of interstitial lung disease in nivolumab‐treated patients with non–small cell lung cancer.
- Published in:
- Cancer Science, 2021, v. 112, n. 4, p. 1506, doi. 10.1111/cas.14715
- By:
- Publication type:
- Article
Radiographic features and poor prognostic factors of interstitial lung disease with nivolumab for non–small cell lung cancer.
- Published in:
- Cancer Science, 2021, v. 112, n. 4, p. 1495, doi. 10.1111/cas.14710
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Cancer Science, 2021, v. 112, n. 4, p. 1333, doi. 10.1111/cas.14466
- Publication type:
- Article
First‐in‐human study of the cancer peptide vaccine TAS0313 in patients with advanced solid tumors.
- Published in:
- Cancer Science, 2021, v. 112, n. 4, p. 1514, doi. 10.1111/cas.14765
- By:
- Publication type:
- Article
Differential prognostic factors in low‐ and high‐burden de novo metastatic hormone‐sensitive prostate cancer patients.
- Published in:
- Cancer Science, 2021, v. 112, n. 4, p. 1524, doi. 10.1111/cas.14722
- By:
- Publication type:
- Article